TRIMETHOPRIM | N017943 | MONARCH PHARMACEUTICALS INC
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| Phase 1/2 | Active | Atsena Therapeutics Inc. | 15 | 2019-10-22 → 2027-05-19 | |
| N/A | Active | Ann & Robert H Lurie Children's Hospital of Chicago | 93 | 2014-03 → 2025-08 | |
| Phase 1/2 | Active | University of Pennsylvania | 8 | 2019-03-27 → 2027-12-30 | |
| N/A | Not Yet Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | 630 | 2026-07-01 → 2029-05-01 | |
| Phase 4 | Recruiting | St. Joseph's Hospital and Medical Center, Phoenix | 116 | 2017-07-01 → 2019-07 | |
| Phase 2 | Recruiting | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 130 | 2012-09-18 → 2027-01-01 | |
| Phase 2 | Recruiting | University of Virginia | 60 | 2026-04-18 → 2026-12-02 | |
| Phase 4 | Recruiting | Fundacion Clinic per a la Recerca Biomédica | 360 | 2022-08-17 → 2027-12-30 | |
| Phase 1 | Recruiting | University of Pennsylvania | 20 | 2020-02-07 → 2027-01 | |
| Phase 4 | Recruiting | Indiana University | 100 | 2025-05-20 → 2027-06 |
Source: ClinicalTrials.gov. Trials matched by ingredient name; data refreshed each weekday and may lag the registry.
8 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Jan 20, 2006 | SUPPL -17 | View Letter (PDF) |
| Aug 26, 2002 | SUPPL -16 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.